Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.
Sakhuja S, Bittner VA, Brown TM, Farkouh ME, Levitan EB, Safford MM, Woodward M, Chen L, Sun R, Dhalwani N, Jones J, Kalich B, Exter J, Muntner P, Rosenson RS, Colantonio LD.
Sakhuja S, et al. Among authors: colantonio ld.
Cardiovasc Drugs Ther. 2024 Oct;38(5):937-945. doi: 10.1007/s10557-023-07452-1. Epub 2023 Apr 13.
Cardiovasc Drugs Ther. 2024.
PMID: 37052867